Clinical Trial Update: Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients [Phase 1, Phase 2]

View source ↗

Summary

An update on early-phase safety and efficacy testing of mesenchymal stem cell therapy in newly diagnosed Type 1 diabetes patients (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University of Sao Paulo | Conditions: Diabetes Mellitus, Insulin-Dependent | Phase 1, Phase 2 | Status: UNKNOWN